AMR - A threat to modern medicine

EHA Library, Sally Davies, 103674

RUNX1 and ETS abnormalities in T-ALL

EHA Library, Vahid Asnafi, 103660

Chromothripsis in ALL - the chromosome 21 model

EHA Library, Christine Harrison, 103659

Gene Therapy

EHA Library, Marina Cavazzana-Calvo, 103617

Genome wide molecular signatures in acute leukemia

EHA Library, Joost Martens, 103658

Novel erythropoiesis stimulating agents in thalassemia

EHA Library, John Porter, 103616

New treatments in SCD

EHA Library, Lucia de Franceschi, 103618

Signaling inhibitors: what is the next step?

EHA Library, John Byrd, 103578

The CLL epigenome: biological and clinical insights

EHA Library, Iñaki Martin-Subero, 103576

The genomic landscape of CLL: clinical implications

EHA Library, Gianluca Gaidano, 103577

PREDICTORS OF MORTALITY IN 100 PATIENTS WITH NEUTROPENIC ENTEROCOLITIS AFTER CYTOTOXIC AGENTS FOR ACUTE MYELOID LEUKEMIA

EHA Library, Novella Pugliese, 100950

INCREASED AND PROLONGED STAT5 ACTIVATION DETECTED FOR A JAK2 E846D GERMLINE MUTATION IN THE SPECIFIC CONTEXT OF EPO RECEPTOR

EHA Library, Katarina Kapralova, 100944

ABERRANT EXPRESSION PROFILES OF HLA-G AND IMMUNOGLOBULIN-LIKE TRANSCRIPTS (ILTS) IN ACQUIRED APLASTIC ANEMIA.

EHA Library, Yuanxin Sun, 100927

SUITABILITY OF THE CAPE BABOON IN HUMAN-TARGETED ANTI-PLATELET STUDIES

EHA Library, Walter Janse Van Rensburg, 100928

PROSPECTIVE ISOLATION OF NOVEL POPULATIONS OF MEGAKARYOCYTE- AND ERYTHROID-PRIMED MEGAKARYOCYTE-ERYTHROID PROGENITORS DEMONSTRATES MEGAKARYOCYTE-BIASED LINEAGE COMMITMENT IN PRIMARY MYELOFIBROSIS

EHA Library, Beth Psaila, 100929

THE ASSOCIATION OF COMBINED ANTIBODY DEFICIENCY AND CHEMOTHERAPY REPRESENTS A HIGH-RISK FACTOR OF NON-NEUTROPENI MAJOR INFECTION IN CLL

EHA Library, Andrea Visentin, 100930

PROGNOSTIC AND THERAPEUTIC IMPLICATIONS OF RAS/RTK PATHWAY MUTATIONS IN DIFFERENT AGE COHORTS OF B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITHOUT KNOWN FUSION TRANSCRIPTS

EHA Library, Monica Messina, 100931

PRE-ENGRAFTMENT SYNDROME AFTER UNRELATED CORD BLOOD TRANSPLANTATION: THE CLINICAL CHARACTERISTICS AND STRATIFIED INTERVENTION TREATMENT

EHA Library, Baolin Tang, 100932

PH-NEGATIVE MPN RED BLOOD CELLS DISPLAY DEREGULATION OF IQGAP1-RHO GTPASE SIGNALING DEPENDING ON CALR/JAK2 STATUS

EHA Library, Nuria Socoro Yuste, 100933

SPECIFIC T-CELL IMMUNE RESPONSES AGAINST AUTOANTIGENS RECOGNIZED BY CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Joanna Zaleska, 100934

KDM5 INHIBITION LEADS TO INCREASED H3K4ME3 LEVELS AND CELL DEATH IN GERMINAL CENTRE LYMPHOMA CELL LINES INDEPENDENT OF MLL2 MUTATION STATUS

EHA Library, Lola Koniali, 100935

PPAR-GAMMA LIGANDS INCREASE ANTILEUKEMIC ACTIVITY OF 2ND AND 3RD GENERATION TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA CELLS

EHA Library, Eliza Glodkowska-Mrowka, 100953

HIGH PROGNOSTIC VALUE OF PRE TRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT BY COMBINED WT1 EXPRESSION AND FLOW CYTOMETRY IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Fabio Guolo, 100952

HIGH RATE OF COMPLETE HEMATOLOGICAL RESPONSE IN ELDERLY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS BY INNOVATIVE SEQUENTIAL USE OF NILOTINIB AND IMATINIB: A GIMEMA CLINICAL TRIAL LAL 1408

EHA Library, Cristina papayannidis, 100951

FUMARATE HYDRATASE IS AN ESSENTIAL REGULATOR OF EMBRYONIC AND ADULT HAEMATOPOIETIC STEM CELL

EHA Library, Amélie Guitart, 100936

DETAILED GENOME ANALYSES REVEAL EXTENSIVE RAG-MEDIATED REARRANGEMENTS IN ADULT ACUTE LEUKEMIA SUBSETS

EHA Library, Mathijs Sanders, 100949

COMBINING IMMUNE CHECKPOINT INHIBITION WITH AMG 330 TO ENHANCE T CELL MEDIATED LYSIS OF PRIMARY AML CELLS

EHA Library, Christina Krupka, 100948

TARGETING ABERRANT NCAM (NEURAL CELL ADHESION MOLECULE; CD56) EXPRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Daniel Sasca, 100947

EVI1 EXPRESSION ASSOCIATES WITH HIGHER CUMULATIVE INCIDENCE OF RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION WITH NON-MYELOABLATIVE CONDITIONING

EHA Library, Marius Bill, 100946

THE PRESENCE OF HEMOGLOBIN S IS ASSOCIATED WITH MIRNA DEREGULATION INCD34+-DERIVED ERYTHROID CELLS

EHA Library, Thais Fornari, 100945

STREAMLINING THE MANAGEMENT OF BLOOD GROUP O RH NEGATIVE BLOOD STOCK: A SINGLE CENTRE IRISH EXPERIENCE

EHA Library, Emma Groarke, 100926

LSD1 IMPAIRS OSTEOCLASTOGENESIS AND EPITHELIAL-MESENCHYMAL TRANSITION IN MM AND ENHANCES HDAC INHIBITORS ACTIVITY

EHA Library, Maria Gkotzamanidou, 100943

SEQUENTIAL EVALUATIONS OF CALR MUTANT BURDEN IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Chiara Cavalloni, 100942

NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA

EHA Library, Sabrina Crivellaro, 100941

GENOTOXIC STRESS MODULATES EVI1 INTERACTION WITH CTBP1 IN ACUTE MYELOID LEUKAEMIA CELLS

EHA Library, Marion Schneider, 100940

NOVEL FUSIONS AND POINT MUTATIONS DETECTED IN NEWLY DIAGNOSED AML PATIENTS BY RNA-SEQ IDENTIFY POTENTIAL NEW TREATMENT OPTIONS

EHA Library, Caterina Cecchetti, 100939

RISK OF VARICELLA-ZOSTER VIRUS INFECTION IN MYELOMA PATIENTS WITHOUT BORTEZOMIB TREATMENT

EHA Library, Chia-Jen Liu, 100938

AGE SPECIFIC INCIDENCE OF PARTNER GENE AND SECONDARY ABNORMALITIES IN MLL POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL)

EHA Library, Alem Gabriel, 100937

iPS from somatically mutated abnormalities

EHA Library, Isabelle Plo, 103652

iPS modeling of severe congenital neutropenia

EHA Library, Jose A. Cancelas, 103653

Management of acute pulmonary embolism

EHA Library, Cecilia Becattini, 103630

New methodologies and monitoring tools for CML

EHA Library, Simona SOVERINI, 103582

Markers and Targets of Neoplastic Stem Cells in CML

EHA Library, Peter VALENT, 103581

Towards culturing granulocytes: Lessons learned from in vitro culture of red blood cells

EHA Library, Ash Toye, 103633

Thrombosis and innate immunity

EHA Library, Bernd Engelmann, 103629

The Efficacy Of Granulocyte Transfusion Therapy

EHA Library, Thomas Price, 103634

Biology of CML

EHA Library, Danilo Perrotti, 103580

The Human Neutrophil Antigen (HNA) System: Structure, Function, And Disease Implications

EHA Library, Juergen Bux, 103632

Coagulation and non-coagulation effects of thrombin

EHA Library, Henri Spronk, 103628

CLINICAL ASSESSMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA SAMPLES FOR SOMATIC HYPERMUTATION STATUS BY NEXT-GENERATION SEQUENCING AND SANGER SEQUENCING

EHA Library, Ying Huang, 100466

DISTINCTIVE GENOTYPES WITH PRENATAL ORIGINS IN INFANT T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Anthony Ford, 100416

A RANDOMISED DE-ESCALATION STUDY OF ORAL FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB IN FIT ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA: WELL TOLERATED AND SUPERIOR OUTCOMES WITH FCR

EHA Library, Stephen Mulligan, 100465

LONG-TERM FOLLOW-UP OF A PHASE IB TRIAL OF IDELALISIB IN COMBINATION WITH CHEMOIMMUNOTHERAPY (CIT) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CLL INCLUDING PATIENTS WITH DEL17P/TP53 MUTATION

EHA Library, Jacqueline Barrientos, 100464

REFINING PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH SOMATICALLY HYPERMUTATED B-CELL RECEPTORS: A NOVEL PROGNOSTIC INDEX ON BEHALF OF THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC)

EHA Library, Panagiotis Baliakas, 100463

THE COMBINATION OF ARSENIC TRIOXIDE AND IBRUTINIB INDUCES SYNERGISTIC APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA THAT IS POTENTLY ASSOCIATED WITH PI3K-AKT DOWN-REGULATION

EHA Library, Xiaohui Zhang, 100462

FUNCTIONAL INVOLVEMENT OF THE SRC KINASE LYN IN THE SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS VIA MAINTENANCE OF ANTI-APOPTOTIC B CELL RECEPTOR SIGNALING

EHA Library, Verena Vondey, 100461

EXTRACELLULAR VESICLES FROM MESENCHYMAL STROMAL CELL MICROENVIRONMENT PROTECT CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS FROM APOPTOSIS

EHA Library, Emerence Crompot, 100460

UPREGULATED COBLL1 IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) PATIENTS WITH UNMUTATED IGHV IDENTIFIES A COHORT WITH INFERIOR PROGNOSIS

EHA Library, Hana Plešingerová, 100459

ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY

EHA Library, Alessandro Morotti, 100458

EXPRESSION AND FUNCTIONAL ROLE OF CORTACTIN IN AGRESSIVENESS AND DIFFUSION OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Veronica Martini, 100457

NOTCH2 AND NOTCH3 HAVE OPPOSITE ROLES IN THE REGULATION OF APOPTOSIS IN CLL CELLS

EHA Library, Rainer Hubmann, 100456

STEM CELL FACTOR KLF4 IS EPIGENETICALLY INACTIVATED AND REPRESSED BY NOTCH SIGNALING IN CLL

EHA Library, Daniel Mertens, 100455

HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE

EHA Library, Andreas Agathangelidis, 100454

IMPORTANCE OF THE B-CELL RECEPTOR ISOTYPE FOR SIGNALING AND FUNCTIONAL RESPONSES IN B CELLS FROM PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jan Burger, 100453

IMPROVED SURVIVAL IN PATIENTS ≥60 WITH FIRST RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA TREATED WITH VOSAROXIN PLUS CYTARABINE VS PLACEBO PLUS CYTARABINE: RESULTS FROM THE PHASE 3 VALOR STUDY

EHA Library, Farhad Ravandi-Kashani, 100452

THE SIGNIFICANCE OF RELATIVE MUTANT LEVEL FOR C-KIT MUTATION IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA BY ALLELE-SPECIFIC REAL-TIME PCR

EHA Library, Eunhee Han, 100451

MICRODUPLICATION 17Q21.31 AND 17P11.2 ASSOCIATE WITH AML DIAGNOSIS OR RESPONSE TO THE THERAPY

EHA Library, Andrzej Lange, 100450

EARLY PERIPHERAL BLAST CELL CLEARANCE PREDICTS MINIMAL RESIDUAL DISEASE STATUS AFTER INDUCTION IN ACUTE MYELOID LEUKEMIA

EHA Library, Francesco Mannelli, 100449

SALVAGE REGIMENT WITH FRACTIONATED GEMTUZUMAB OZOGAMICIN, INTERMEDIATE DOSE CYTARABINE AND MITOXANTRONE (MYLODAM) FOR REFRACTORY AND RELAPSED AML: A SINGLE CENTER EXPERIENCE.

EHA Library, Anne-Claire Mamez, 100448

CD200 EXPRESSION IS ASSOCIATED WITH INFERIOR RESPONSE AND POOR SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Mario Tiribelli, 100447

MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS

EHA Library, Debora Capelli, 100446

PROSPECTIVE STUDY ON 220 NEUTROPENIC EPISODES IN 109 AML PATIENTS. ROLE OF BED-SIDE ULTRASOUND (BUS) IN NEUTROPENIC ENTEROCLITIS (NEC): INCIDENCE AND SURVIVAL WITH DIFFERENT CHEMOTHERAPY REGIMEN.

EHA Library, Edoardo Benedetti, 100445

RELAPSE CHARACTERISTICS AND RISK FACTORS FOR CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ACUTE PROMYELOCYTIC LEUKAEMIA IN THE ORAL ARSENIC TRIOXIDE ERA – A 13-YEAR FOLLOW-UP STUDY

EHA Library, Harinder Gill, 100444

ALLOGENEIC TRANSPLANT IN PATIENTS ≥60 YEARS OF AGE WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA AFTER TREATMENT WITH VOSAROXIN OR PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR

EHA Library, Farhad Ravandi-Kashani, 100443

RESIDUAL HEMATOPOIETIC STEM CELLS REFLECT MINIMAL RESIDUAL DISEASE AND PREDICT OUTCOME IN ACUTE MYELOID LEUKEMIA

EHA Library, Wenwen Wang, 100442

DEFINITION OF CURE IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Gevorg Tamamyan, 100441

THE EFFECT OF AZACITIDINE ON HEALTH-RELATED QUALITY OF LIFE (HRQL) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE AZA-AML-001 TRIAL

EHA Library, Mark D.Minden, 100440

FLUDARABINE-CONTAINING INDUCTION INCREASES MINIMAL RESIDUAL DISEASE CLEARENCE AND IMPROVES SURVIVAL IN AML PATIENTS WITH CONCOMITANT NPM1 AND FLT3-ITD MUTATIONS

EHA Library, Fabio Guolo, 100439

A COMPARISON OF DAUNORUBICIN/ CLOFARABINE AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 TRIAL

EHA Library, Alan Burnett, 100438

EVALUATION OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA – RESULTS OF THE FRENCH MULTICENTER ELAM02 TRIAL

EHA Library, Hélène Lapillonne, 100437

THE LEUKEMIA-ASSOCIATED RUNX1/ETO ONCOPROTEIN CONFERS A MUTATOR PHENOTYPE

EHA Library, Victoria Forster, 100436

MICRORNA-182, C/EBPΑ AND E2F GENERATE AN AUTOREGULATORY FEEDBACK NETWORK WHICH IS DYSREGULATED IN ACUTE MYELOID LEUKEMIA

EHA Library, Alexander Arthur Wurm, 100435

SURVIVAL PREDICTION AND IDENTIFICATION OF KEY PROGNOSTIC PROTEINS IN ACUTE MYELOID LEUKEMIA USING REVERSE PHASE PROTEIN ARRAY

EHA Library, Erel Joffe, 100434

DIFFERENTIAL RESPONSIVENESS OF PML-RARA CARRYING VARIOUS POINT MUTATIONS TO ARSENIC TRIOXIDE

EHA Library, Jiangying Liu, 100433

GENETIC AND EPIGENETIC EVOLUTION DURING THE PROGRESSION OF CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML)

EHA Library, Sebastian Vosberg, 100432

THE CXCR4 ANTAGONIST BL-8040 DIRECTLY AFFECTS AML BLASTS BY INDUCING THEIR TERMINAL DIFFERENTIATION AND BLOCKING SURVIVAL SIGNALS

EHA Library, Yaron Pereg, 100431

REDEFINE CLINICAL RISK CLASSIFICATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA USING INITIAL ABSOLUTE LYMPHOCYTE COUNT

EHA Library, Koramit Suppipat, 100430

ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO HAD CENTRAL NERVOUS SYSTEM INVOLVEMENT: A STUDY FROM THE ADULT ALL WORKING GROUP OF THE JSHCT

EHA Library, Akio Shigematsu, 100429

ADAM28 OVEREXPRESSION REGULATED THROUGH PI3K/AKT PATHWAY IS ASSOCIATED WITH POOR PROGNOSIS IN DE NOVO ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Xiaohui Zhang, 100428

CENTRAL NERVOUS SYSTEM AS AN IMMUNOLOGICAL SANCTUARY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: ROLE OF NATURAL KILLER CELLS.

EHA Library, Shai Izraeli, 100427

RETREATMENT WITH BLINATUMOMAB AFTER CD19-POSITIVE RELAPSE: EXPERIENCE FROM 3 TRIALS IN PATIENTS WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL)

EHA Library, Max Topp, 100426

CHARACTERIZATION OF LEF1 HIGH EXPRESSION AND NOVEL MUTATIONS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zheng Ge, 100424

INFLUENCE OF BASELINE FACTORS ON OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL) TREATED WITH BLINATUMOMAB

EHA Library, Max Topp, 100423

TUMOR SUPPRESSOR GENES IKZF1 AND BTG1 COOPERATE IN ACUTE LYMPHOBLASTIC LEUKEMIA DEVELOPMENT AND GLUCOCORTICOID THERAPY RESISTANCE

EHA Library, Blanca Scheijen, 100422

TP53 MUTATIONS IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) DEFINE A GROUP OF VERY HIGH RISK PATIENTS: A NEXT GENERATION SEQUENCING (NGS) STUDY.

EHA Library, Orietta Spinelli, 100421

THE STEMNESS INHIBITOR, BBI608, REDUCES THE SELF-RENEWAL OF BCR-ABL1 POSITIVE LEUKEMIA CELLS.

EHA Library, Tetsuzo Tauchi, 100420

RESTORING IKAROS TUMOR SUPPRESSION AS A THERAPY FOR HIGH-RISK LEUKEMIA

EHA Library, Chunhua song, 100419

CLONAL ARCHITECTURES OF BCR-ABL+ BCP-ALL: IMPLICATIONS FOR ANTI B-CELL DIRECTED THERAPY

EHA Library, Marius Bartels, 100418

DUAL SMALL MOLECULE INHIBITORS TARGETING G9A AND DNMTS: A NOVEL STRATEGY FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Felipe Prosper, 100417

HEALTH RELATED QUALITY OF LIFE AND PATIENT REPORTED OUTCOMES IN PATIENTS RECEIVING OFATUMUMAB MAINTENANCE VERSUS OBSERVATION IN THE PROLONG TRIAL

EHA Library, Stephanie Manson, 100467